UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bendamustine With Dexamethasone in Relapsed/Refractory Systemic Light-Chain Amyloidosis: Results of a Phase II Study

Journal of clinical oncology, 2020-05, Vol.38 (13), p.1455-1462

2020

Volltextzugriff (PDF)

Editorial: Expert opinions in genitourinary oncology

Frontiers in oncology, 2023, Vol.13, p.1360223-1360223

2023

Volltextzugriff (PDF)

Targeting S100A9-ALDH1A1-Retinoic Acid Signaling to Suppress Brain Relapse in EGFR-Mutant Lung Cancer

Cancer discovery, 2022-04, Vol.12 (4), p.1002-1021

2022

Volltextzugriff (PDF)

Ductal, intraductal, and cribriform carcinoma of the prostate: Molecular characteristics and clinical management

Urologic oncology, 2024-05, Vol.42 (5), p.144-154

2024

Volltextzugriff (PDF)

Synchronous Pulmonary Adenocarcinomas

American journal of clinical pathology, 2020-06, Vol.154 (1), p.57-69

2020

Volltextzugriff (PDF)

Single-cell RNA sequencing reveals distinct T cell populations in immune-related adverse events of checkpoint inhibitors

Cell reports. Medicine, 2023-01, Vol.4 (1), p.100868, Article 100868

2023

Volltextzugriff (PDF)

Synchronous Pulmonary Adenocarcinomas: Correlation Among Morphology, Next-Generation Sequencing/Single-Gene Analysis Molecular Testing, and Clinical Outcomes With Eighth Edition AJCC Criteria

American journal of clinical pathology, 2020-07, Vol.154 (1), p.57-69

2020

Volltextzugriff (PDF)

443 Pembrolizumab for BCG refractory non-muscle invasive bladder cancer yields poor recurrence-free survival and high toxicity in patients

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A492-A492

2023

Volltextzugriff (PDF)

Beyond Tumor PD-L1: Emerging Genomic Biomarkers for Checkpoint Inhibitor Immunotherapy

American Society of Clinical Oncology educational book, 2020-05, Vol.40 (40), p.1-e57

2020

Volltextzugriff (PDF)

Updated analysis of phase 2 study of bendamustine and dexamethasone in patients with relapsed/refractory systemic light chain (AL) amyloidosis

Amyloid, 2019-03, Vol.26 (sup1), p.113-114

2019

Volltextzugriff (PDF)

Clinical features of patients with MTAP -deleted bladder cancer

American journal of cancer research, 2023-01, Vol.13 (1), p.326-339

2023

Volltextzugriff (PDF)

Hepatoid Adenocarcinoma of the Lung Responsive to Frontline Combination Chemotherapy With Immunotherapy: Case Report

JTO clinical and research reports, 2021-02, Vol.2 (2), p.100130, Article 100130

2021

Volltextzugriff (PDF)

Evolution of the HIF targeted therapy in clear cell renal cell carcinoma

Cancer treatment reviews, 2023-12, Vol.121, p.102645-102645, Article 102645

2023

Volltextzugriff (PDF)

Germline mutational profile in metastatic urothelial malignancy

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.550-550

2023

Volltextzugriff (PDF)

Adverse effects and discontinuation of pembrolizumab in BCG refractory non-muscle invasive bladder cancer

Journal of clinical oncology, 2024-02, Vol.42 (4_suppl), p.588-588

2024

Volltextzugriff (PDF)

Characteristics of patients with EGFR -mutant non-small cell lung cancer (NSCLC) at a diverse metropolitan cancer center

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e20593-e20593

2022

Volltextzugriff (PDF)

Using pan-sarcoma multiomic analysis for identifying sarcoma subtypes with immunogenic potential

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.11551-11551

2022

Volltextzugriff (PDF)

Baseline peripheral T-cell composition in relation to radiographic phenotypes of immune-related pneumonitis

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.2545-2545

2022

Volltextzugriff (PDF)

Abstract CT085: Targeting androgen signaling in urothelial carcinoma

Cancer research (Chicago, Ill.), 2024-04, Vol.84 (7_Supplement), p.CT085-CT085

2024

Volltextzugriff (PDF)

Age as a factor in the molecular landscape and the tumor-microenvironmental signature of osteosarcoma

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.11525-11525

2022

Volltextzugriff (PDF)

Multiomic analysis to reveal distinct molecular profiles of uterine and nonuterine leiomyosarcoma

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.11555-11555

2021

Volltextzugriff (PDF)

Large scale multiomic analysis suggests mechanisms of resistance to immunotherapy in leiomyosarcoma

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.11512-11512

2021

Volltextzugriff (PDF)

Characteristics and outcomes of Latino patients with EGFR-mutant NSCLC

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e13578-e13578

2018

Volltextzugriff (PDF)

Abstract 2567: An analysis of proviral insertion site of Moloney murine leukemia virus, PIM1, kinase expression and clinical outcomes in renal cell carcinoma

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.2567-2567

2024

Volltextzugriff (PDF)

Long Term Follow up of Patients with Relapsed/Refractory Systemic Light Chain (AL) Amyloidosis Treated with Bendamustine and Dexamethasone in a Phase 2 Study

Blood, 2017-12, Vol.130, p.1838-1838

2017

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(27)

Publikationsform

Sprache

Englisch
(33)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Bendamustine With Dexamethasone in Relapsed/Refractory Systemic Light-Chain Amyloidosis: Results of a Phase II Study

Editorial: Expert opinions in genitourinary oncology

Targeting S100A9-ALDH1A1-Retinoic Acid Signaling to Suppress Brain Relapse in EGFR-Mutant Lung Cancer

Ductal, intraductal, and cribriform carcinoma of the prostate: Molecular characteristics and clinical management

Synchronous Pulmonary Adenocarcinomas

Single-cell RNA sequencing reveals distinct T cell populations in immune-related adverse events of checkpoint inhibitors

Synchronous Pulmonary Adenocarcinomas: Correlation Among Morphology, Next-Generation Sequencing/Single-Gene Analysis Molecular Testing, and Clinical Outcomes With Eighth Edition AJCC Criteria

443 Pembrolizumab for BCG refractory non-muscle invasive bladder cancer yields poor recurrence-free survival and high toxicity in patients

Beyond Tumor PD-L1: Emerging Genomic Biomarkers for Checkpoint Inhibitor Immunotherapy

Updated analysis of phase 2 study of bendamustine and dexamethasone in patients with relapsed/refractory systemic light chain (AL) amyloidosis

Clinical features of patients with MTAP -deleted bladder cancer

Hepatoid Adenocarcinoma of the Lung Responsive to Frontline Combination Chemotherapy With Immunotherapy: Case Report

Evolution of the HIF targeted therapy in clear cell renal cell carcinoma

Germline mutational profile in metastatic urothelial malignancy

Adverse effects and discontinuation of pembrolizumab in BCG refractory non-muscle invasive bladder cancer

Characteristics of patients with EGFR -mutant non-small cell lung cancer (NSCLC) at a diverse metropolitan cancer center

Using pan-sarcoma multiomic analysis for identifying sarcoma subtypes with immunogenic potential

Baseline peripheral T-cell composition in relation to radiographic phenotypes of immune-related pneumonitis

Abstract CT085: Targeting androgen signaling in urothelial carcinoma

Age as a factor in the molecular landscape and the tumor-microenvironmental signature of osteosarcoma

Multiomic analysis to reveal distinct molecular profiles of uterine and nonuterine leiomyosarcoma

Large scale multiomic analysis suggests mechanisms of resistance to immunotherapy in leiomyosarcoma

Characteristics and outcomes of Latino patients with EGFR-mutant NSCLC

Abstract 2567: An analysis of proviral insertion site of Moloney murine leukemia virus, PIM1, kinase expression and clinical outcomes in renal cell carcinoma

Long Term Follow up of Patients with Relapsed/Refractory Systemic Light Chain (AL) Amyloidosis Treated with Bendamustine and Dexamethasone in a Phase 2 Study

Suchergebnisse filtern